Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in NTLA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ARK Investment Management LLC | 14.5M | $186.0M | +2.1% | 12.930% | 1.45% |
| 2 | BlackRock, Inc. | 12.2M | $155.8M | +18.3% | 10.833% | 0.00% |
| 3 | STATE STREET CORP | 6.9M | $88.7M | +7.8% | 6.169% | 0.00% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.2M | $79.8M | β | 5.546% | 0.00% |
| 5 | D. E. Shaw & Co., Inc. | 5.7M | $73.4M | β | 5.105% | 0.07% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $65.2M | β | 4.531% | 0.00% |
| 7 | TWO SIGMA INVESTMENTS, LP | 4.7M | $60.3M | +74.4% | 4.194% | 0.05% |
| 8 | REGENERON PHARMACEUTICALS, INC. | 3.7M | $47.5M | 0.0% | 3.300% | 99.14% |
| 9 | UBS Group AG | 3.3M | $41.8M | +163.2% | 2.904% | 0.01% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.9M | $36.6M | +5.8% | 2.541% | 0.00% |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.7M | $34.6M | +43.1% | 2.409% | 0.00% |
| 12 | DIMENSIONAL FUND ADVISORS LP | 2.3M | $29.7M | +20.0% | 2.066% | 0.01% |
| 13 | MORGAN STANLEY | 2.1M | $26.7M | -10.6% | 1.855% | 0.00% |
| 14 | FMR LLC | 2.1M | $26.5M | +17.5% | 1.842% | 0.00% |
| 15 | Sumitomo Mitsui Trust Holdings, Inc. | 2.0M | $25.3M | -10.0% | 1.758% | 0.02% |
| 16 | Nikko Asset Management Americas, Inc. | 2.0M | $25.3M | -10.0% | 1.758% | 0.36% |
| 17 | Contrarius Group Holdings Ltd | 1.9M | $24.5M | +167.6% | 1.704% | 1.39% |
| 18 | JUPITER ASSET MANAGEMENT LTD | 1.8M | $22.8M | +71.6% | 1.587% | 0.12% |
| 19 | GOLDMAN SACHS GROUP INC | 1.6M | $20.9M | +11.9% | 1.451% | 0.00% |
| 20 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.6M | $20.7M | -7.2% | 1.436% | 0.08% |
| 21 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.4M | $17.9M | β | 1.245% | 0.01% |
| 22 | BANK OF AMERICA CORP /DE/ | 1.4M | $17.7M | +11.2% | 1.231% | 0.00% |
| 23 | CITADEL ADVISORS LLC | 1.1M | $14.3M | -47.7% | 0.996% | 0.01% |
| 24 | STIFEL FINANCIAL CORP | 1.0M | $13.0M | +8.7% | 0.902% | 0.01% |
| 25 | NORTHERN TRUST CORP | 966K | $12.4M | +10.7% | 0.861% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in NTLA β a direct measure of their conviction.
Filings activity in NTLA during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new NTLA position in Q1 2026
Institutions that fully closed their NTLA position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 294 | +2.4% | 105.20% | +38.33 pp | $1.43B | +57% |
| Q4 2025 | 287 | +6.3% | 66.87% | 66.80 pp | $909M | 50% |
| Q3 2025 | 270 | +0.0% | 133.67% | +65.62 pp | $1.82B | +96% |
| Q2 2025 | 270 | 4.3% | 68.05% | +17.26 pp | $925M | +34% |
| Q1 2025 | 282 | 0.7% | 50.79% | 30.04 pp | $690M | 37% |
| Q4 2024 | 284 | +4.8% | 80.83% | 53.34 pp | $1.10B | 40% |
| Q3 2024 | 271 | 3.9% | 134.17% | 10.57 pp | $1.82B | 7.3% |
| Q2 2024 | 282 | β | 144.74% | β | $1.97B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying NTLA stock.
Based on Q1 2026 13F filings, institutional ownership of Intellia Therapeutics, Inc. stands at 105.2%, held across 294 reporting institutions.
ARK Investment Management LLC is the largest reported institutional holder of NTLA, with approximately 14,509,247 shares worth $0.19B as of Q1 2026.
Yes β 4 widely-followed marquee investors appear among the top 25 institutional holders of NTLA, including ARK Investment Management LLC, TWO SIGMA INVESTMENTS, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC.
Our composite Smart Money Score for NTLA is 72 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
63 institutions opened new positions in NTLA during Q1 2026, while 56 fully exited. 204 added to existing positions and 25 trimmed.
NTLA institutional ownership rose by 38.33 percentage points quarter-over-quarter, with a net change of +7 holders.
The top 10 institutions account for 58.4% of all reported 13F value in NTLA, and the top 25 account for 81.7%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Intellia Therapeutics, Inc. (NTLA) Institutional Ownership